Acquisition Momentum Interius BioTherapeutics was acquired by Kite Pharma for $350 million, indicating significant corporate validation and potential for expanded sales channels through Gilead's global network and resources.
Innovative Therapies The company is developing next-generation CAR T and CAR NK therapies using novel in vivo delivery technologies, presenting opportunities to offer complementary products or services to enhance or accelerate their pipeline.
Geographic Expansion Recent approval to expand Phase 1 clinical trials into Europe suggests potential to collaborate with international suppliers, clinical research organizations, and healthcare providers seeking innovative cell therapy solutions.
R&D Focus With recent hires of senior scientists and a focus on developing faster, more affordable, and accessible therapies, there are opportunities to introduce R&D tools, manufacturing equipment, or clinical trial services aligned with their goals.
Financial Opportunity Interius BioTherapeutics operates within a revenue range of 25M to 50M and is actively advancing clinical trials, indicating ongoing demand for biotech services, bioprocessing technologies, and strategic partnerships to support their growth.
$1M$10M
$1B$10B
$1M
$50M$100M
$250M$500M
$100M$250M
$1M$10M
$250M$500MInterius Biotherapeutics uses 8 technology products and services including Open Graph, oEmbed, jQuery, and more. Explore Interius Biotherapeutics's tech stack below.
| Interius Biotherapeutics Email Formats | Percentage |
| First.Last@interiusbio.com | 49% |
| First.Middle@interiusbio.com | 1% |
| First.Last@interiusbio.com | 49% |
| First.Middle@interiusbio.com | 1% |
Biotechnology ResearchPennsylvania, United States11-50 Employees
Interius BioTherapeutics is now part of Kite, a Gilead Company. Kite is a global biopharmaceutical company based in Santa Monica, California, focused on achieving cures with cell therapy. For more information on Kite, please visit www.kitepharma.com and follow Kite Pharma on LinkedIn for updates. Note: Comments on the Interius BioTherapeutics LinkedIn page are not actively monitored.
Company Overview
Funding & FinancialsInterius Biotherapeutics's revenue is estimated to be in the range of $10M$25M
Funding & FinancialsInterius Biotherapeutics's revenue is estimated to be in the range of $10M$25M
1-888-653-2347 
support@leadiq.com